[Subsequent manic onset caused by association of vigabatrin-clomipramine].
Sastre-Garau
P
P
Thomas
P
P
Beaussart
M
M
Goudemand
M
M
D000328:Adult; D000614:Aminocaproates / Q000009:adverse effects* / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000139:chemically induced* / Q000523:psychology; D002997:Clomipramine / Q000009:adverse effects* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004359:Drug Therapy, Combination; D004569:Electroencephalography / Q000187:drug effects; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D008297:Male; D020888:Vigabatrin
D000614:Aminocaproates; D000927:Anticonvulsants; D020888:Vigabatrin; D002997:Clomipramine
Accès maniaque consécutif à une association vigabatrin-clomipramine.